Fan Zhu

Fan Zhu

Auto-generated profile, based on publicly available information

Fan Zhu

Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Food & Function
Verified
Journal Article
Closed access
PDF file
JZJuanjuan Zhang
Juanjuan Zhang
FZFan Zhu
Fan Zhu
ZCZhixia Cao
Zhixia Cao
SRSabina Rayamajhi
Sabina Rayamajhi
QZQing Zhang
Qing Zhang
Kaijun NiuKaijun Niu
Kaijun Niu
Background: prospective cohort studies linking ultra-processed foods (UPF) and subclinical thyroid dysfunction (SCTD) are limited, especially in Chinese adults. Objective: we designed a large-scale cohort study to examine whether UPF consumption is a risk factor for SCTD in adults. Methods: this prospective cohort study investigated 8732 participants (mean age: 44.7 ± 10.7 years; 53.3% men). UPF consumption was measured at the baseline using a validated food frequency questionnaire and classified according to the NOVA classification system. SCTD was characterized by abnormal serum thyroid-stimulating hormone levels and normal free thyroxine. Cox proportional hazards regression models were used to examine the association of UPF consumption with the risk of various types of SCTD. Results: during the follow-up period, the incidence rate of subclinical hypothyroidism was 8.3/1000 person-years and that of subclinical hyperthyroidism was 7.0/1000 person-years. After adjusting the potential confounding factors, the multivariable hazard ratios (HRs) (95% confidence intervals) across increasing tertiles of energy-adjusted UPF consumption for subclinical hypothyroidism were 1.00 (reference), 0.82 (0.57, 1.18) and 0.87 (0.60, 1.27) (P for trend = 0.47) and for subclinical hyperthyroidism were 1.00 (reference), 1.09 (0.71, 1.68) and 1.69 (1.12, 2.56) (P for trend = 0.01). Per one standard deviation (58.0 g per 1000 kcal per day) increase in ultra-processed food consumption a 14% increase in risk of subclinical hyperthyroidism was observed (HR = 1.14; 95% CI: 1.00, 1.30; P = 0.04). Further sensitivity analysis showed that the fully adjusted HRs (95% CIs) of subclinical hyperthyroidism across tertiles of the proportion of UPF in weight for subclinical hyperthyroidism were 1.00 (reference), 1.06 (0.69, 1.63) and 1.63 (1.09, 2.46) (P for trend = 0.01). Conclusions: this population-based prospective cohort study has firstly demonstrated that higher UPF consumption was associated with higher risk of subclinical hyperthyroidism in adults. The UMIN clinical trial registry number is UMIN000027174 (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031137).

2 December 2021 in Vascular
Verified
Journal Article
Closed access
PDF file
FZFan Zhu
Fan Zhu
JCJia Chen
Jia Chen
MLMingyao Luo
Mingyao Luo
DYDongting Yao
Dongting Yao
XHXiaobo Hu
Xiaobo Hu
YGYuanyuan Guo
Yuanyuan Guo
Objectives: To evaluate the potential effect of EphrinB2 in human thoracic aortic dissection (TAD) and to illustrate the mechanisms governing the role of EphrinB2 in the growth of human aortic smooth muscle cells (HASMC). Methods: In the study, EphrinB2 expression was investigated by qRT-PCR and immunohistochemistry in 12 pairs of TAD and adjacent human tissues. HASMCs were used for in vitro experiments. Next, EphrinB2 overexpression and depletion in HASMCs were established by EphrinB2-overexpressing vectors and small interfering RNA, respectively. The transfection efficiency was evaluated by qRT-PCR and Western blot. The effects of overexpression and depletion of EphrinB2 on cell proliferation, migration, and invasion were tested in vitro. Cell Counting Kit-8, flow cytometry and transwell migration/invasion, and wound healing assay were used to explore the function of EphrinB2 on HASMC cell lines. The relationship between EphrinB2 and F-actin was assessed by Western blot, immunofluorescence, and Co-IP. Results: We found that EphrinB2 was a prognostic biomarker of TAD patients. Moreover, EphrinB2 expression negatively correlated to aortic dissection tissues, and disease incidence of males, suggesting that EphrinB2 might act as a TAD suppressor by promoting proliferation or decreasing apoptosis in HASMC. Next, over-expression of EphrinB2 in HASMC lines drove cell proliferation, migration, and invasion, and inhibited apoptosis while knockdown EphrinB2 showed the opposite phenomenon, respectively. Furthermore, the level of F-actin in mRNA, protein, and distribution in HASMC cell lines highly matched with the expression of EphrinB2, which indicated that EphrinB2 could mediate the HASMC cytoskeleton via inducing F-actin. Conclusions: In conclusion, our results first provided the pivotal role of EphrinB2 in HASMC proliferation initiated by mediating F-actin and demonstrated a prognostic biomarker and the potential targets for therapy to prevent thoracic aortic dissection.